4 completed. 2 Not applicable, 1 Early Phase 1, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Clasado: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GOS to Reduce Symptom Severity in IBS Galacto-oligosaccharides (GOS), Maltodextrine - Irritable Bowel Syndrome, Irritable Bowel Syndrome - Constipation | Not applicable | Completed | Clasado | 153 | 2021-10-26 | 2024-10-18 |
| The Effect of Feeding Infant Formula With Bimuno Galactooligosaccharide (GOS) GOS, B-GOS 3%, B-GOS 2% - Dietary Modification | Not applicable | Completed | Clasado | 392 | 2016-06-01 | 2017-07-19 |
| The Effect of Prebiotic B-GOS on the Immune Function, Metabolism and Gut Microbiota of Elderly People Bi2muno® GOS, Maltodextrin - Immunosenescence | Early Phase 1 | Completed | Clasado | 40 | 2011-05-01 | 2016-03-25 |
| Efficacy of a Prebiotic Galactooligosaccharide to Reduce Metabolic Syndrome Risk Factors in Overweight Adults Bimuno, Maltodextrin - Metabolic Syndrome X | Phase 1 / Phase 2 | Completed | Clasado | 48 | 2009-10-01 | 2016-03-25 |
Constipation (1) · Diarrhea (1) · Irritable Bowel Syndrome (1) · Metabolic Syndrome (1)
4'-galactooligosaccharide (2) · maltodextrin (2) · Dextrins (1) · Prebiotics (1)
United Kingdom (3) · Belgium (1) · Netherlands (1)
Glenn Gibson, PhD (1) · Jelena Vulevic, PhD (1) · Lucien F. Harthoorn, PhD. (1)